Design and synthesis of new indanol-1,2,3-triazole derivatives as potent antitubercular and antimicrobial agents
作者:Pramod S. Phatak、Rajubai D. Bakale、Ravibhushan S. Kulkarni、Sambhaji T. Dhumal、Prashant P. Dixit、Vagolu Siva Krishna、Dharmarajan Sriram、Vijay M. Khedkar、Kishan P. Haval
DOI:10.1016/j.bmcl.2020.127579
日期:2020.11
antitubercular agents, herein we have reported a series of new thirty-two indanol-1,2,3-triazole derivatives. The synthesized compounds were screened for their in vitro antitubercular and antimicrobial activities. Among the screened compounds, most of the compounds have displayed good antitubercular activity against Mycobacterium tuberculosis H37Rv. The compound 5g has been identified as potent antitubercular
为了寻找新的抗结核药,我们在此报道了一系列新的三十二种茚满醇-1,2,3-三唑衍生物。筛选合成的化合物的体外抗结核和抗菌活性。在筛选的化合物中,大多数化合物对结核分枝杆菌H37Rv表现出良好的抗结核活性。化合物5g已被确定为有效的抗结核药,MIC值为1.56 µM。使用MTT分析进一步研究了该系列中活性最高的化合物对HEK 293细胞的细胞毒性,发现无毒。另外,显示出十种化合物对抗菌和抗真菌病原体均具有良好的抗菌活性。针对的分子对接研究进行了分枝杆菌烯酰-ACP-还原酶(InhA)以深入了解抗结核作用的分子机制。研究了这些化合物的药代动力学参数,并显示了可接受的药物相似度评分。